At Janssen we address innovation from a scientific point of view, applied in 5 therapeutic areas: Oncology, Immunology, Central Nervous System, Cardiovascular & Metabolics and Infectious Diseases.

These therapeutic areas concentrate a high volume of patients with chronic diseases which require specialized care and treatments. The most effective and safe alternatives for these pathologies are a product of important investigations and developments, oriented to the search of the wellbeing and quality of life of the patients.

At Janssen, we believe in research and science to develop new ideas and materialize them in medical solutions transformed for the benefit of the patients. Once we have turned the best science in transformational medicine, we want to make sure that people have access to our medications and also that they are used in the best possible way during the course of the treatment. This may require education programs to better understand the diseases or services and support for the patients, amongst other actions.

Janssen Global Public Health complements the scientific group with innovating strategies that improves the access to medications, promote collaboration and support public health solutions for a sustainable progress of healthcare in the world. The current areas of main interest include multidrug-resistant tuberculosis (MDR-TB) and the human immunodeficiency virus (HIV).